Hüper, L.* ; Steinacker, P.* ; Polyakova, M.* ; Mueller, K.* ; Godulla, J.* ; Herzig, S.* ; Danek, A.* ; Engel, A.* ; Diehl-Schmid, J.* ; Classen, J.* ; Fassbender, K.* ; Fliessbach, K.* ; Jahn, H.* ; Kassubek, J.* ; Kornhuber, J.* ; Landwehrmeyer, B.* ; Lauer, M.* ; Obrig, H.* ; Oeckl, P.* ; Prudlo, J.* ; Saur, D.* ; Anderl-Straub, S.* ; Synofzik, M.* ; Wagner, M. ; Wiltfang, J.* ; Winkelmann, J. ; Volk, A.E.* ; Huppertz, H.J.* ; Otto, M.* ; Schroeter, M.L.*
Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers.
Alzheimers Dement., DOI: 10.1002/alz.13863 (2024)
INTRODUCTION: Frontotemporal lobar degeneration (FTLD) encompasses behavioral variant frontotemporal dementia (bvFTD), progressive supranuclear palsy, corticobasal syndrome/degeneration, and primary progressive aphasias (PPAs). We cross-validated fluid biomarkers and neuroimaging. METHODS: Seven fluid biomarkers from cerebrospinal fluid and serum were related to atrophy in 428 participants including these FTLD subtypes, logopenic variant PPA (lvPPA), Alzheimer's disease (AD), and healthy subjects. Atrophy was assessed by structural magnetic resonance imaging and atlas-based volumetry. RESULTS: FTLD subtypes, lvPPA, and AD showed specific profiles for neurofilament light chain, phosphorylated heavy chain, tau, phospho-tau, amyloid beta1-42 from serum/cerebrospinal fluid, and brain atrophy. Neurofilaments related to regional atrophy in bvFTD, whereas progranulin was associated with atrophy in semantic variant PPA. Ubiquitin showed no effects. DISCUSSION: Results specify biomarker and atrophy patterns in FTLD and AD supporting differential diagnosis. They identify neurofilaments and progranulin in interaction with structural imaging as promising candidates for monitoring disease progression and therapy. HIGHLIGHTS: Study cross-validated neuroimaging and fluid biomarkers in dementia. Five kinds of frontotemporal lobar degeneration and two variants of Alzheimer's disease. Study identifies disease-specific fluid biomarker and atrophy profiles. Fluid biomarkers and atrophy interact in a disease-specific way. Neurofilaments and progranulin are proposed as biomarkers for diagnosis and therapy.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Amyloid ; Atrophy ; Fluid Biomarkers ; Frontotemporal Dementia ; Frontotemporal Lobar Degeneration ; Magnetic Resonance Imaging ; Neurofilaments ; Phospho‐tau ; Progranulin ; Tau ; Ubiquitin; Cerebrospinal-fluid; Probabilistic Atlas; Behavioral Variant; Tau-protein; Human Brain; Neurodegenerative Diseases; Alzheimers-disease; Light-chain; Large-scale; Dementia
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
1552-5260
e-ISSN
1552-5279
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band:
Heft:
Seiten:
Artikelnummer:
Supplement:
Reihe
Verlag
Elsevier
Verlagsort
New York, NY [u.a.]
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-503200-001
Förderungen
Projekt DEAL
Predoc Award Program of the University of Leipzig
Max Planck Society and, along
International Max Planck Research School on Neuroscience of Communication
Saxon state parliament
EHealthSax Initiative of the Saechsische Aufbaubank
EU
German Federal Ministry of Education and Research
German Research Foundation
Copyright
Erfassungsdatum
2024-06-18